These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
322 related articles for article (PubMed ID: 2706631)
1. Modulation by CR-1409 (lorglumide), a cholecystokinin receptor antagonist, of trypsin inhibitor-enhanced growth of azaserine-induced putative preneoplastic lesions in rat pancreas. Douglas BR; Woutersen RA; Jansen JB; de Jong AJ; Rovati LC; Lamers CB Cancer Res; 1989 May; 49(9):2438-41. PubMed ID: 2706631 [TBL] [Abstract][Full Text] [Related]
2. Stimulation of growth of azaserine-induced putative preneoplastic lesions in rat pancreas is mediated specifically by way of cholecystokinin-A receptors. Povoski SP; Zhou W; Longnecker DS; Roebuck BD; Bell RH Cancer Res; 1993 Sep; 53(17):3925-9. PubMed ID: 8358719 [TBL] [Abstract][Full Text] [Related]
3. Comparison of the effect of lorglumide on pancreatic growth stimulated by camostate in rat and hamster. Douglas BR; Woutersen RA; Jansen JB; Rovati LC; Lamers CB Life Sci; 1990; 46(4):281-6. PubMed ID: 2304371 [TBL] [Abstract][Full Text] [Related]
4. Stimulation of the growth of azaserine-induced nodules in the rat pancreas by dietary camostate (FOY-305). Lhoste EF; Roebuck BD; Longnecker DS Carcinogenesis; 1988 Jun; 9(6):901-6. PubMed ID: 3259478 [TBL] [Abstract][Full Text] [Related]
5. Pancreatic growth: interaction of exogenous cholecystokinin, a protease inhibitor, and a cholecystokinin receptor antagonist in mice. Niederau C; Liddle RA; Williams JA; Grendell JH Gut; 1987; 28 Suppl(Suppl):63-9. PubMed ID: 2446964 [TBL] [Abstract][Full Text] [Related]
6. Effects of the synthetic trypsin inhibitor camostate on the development of N-nitrosobis(2-oxopropyl)amine-induced pancreatic lesions in hamsters. Meijers M; van Garderen-Hoetmer A; Lamers CB; Rovati LC; Jansen JB; Woutersen RA Cancer Lett; 1991 Dec; 60(3):205-11. PubMed ID: 1756510 [TBL] [Abstract][Full Text] [Related]
7. Influence of cholecystokinin antagonist on the effects of cholecystokinin and bombesin on azaserine-induced lesions in rat pancreas. Douglas BR; Woutersen RA; Jansen JB; de Jong AJ; Rovati LC; Lamers CB Gastroenterology; 1989 Feb; 96(2 Pt 1):462-9. PubMed ID: 2910761 [TBL] [Abstract][Full Text] [Related]
8. Growth of azaserine-induced putative preneoplastic nodules in the rat pancreas is mediated specifically by way of cholecystokinin-A receptors. Povoski SP; Zhou W; Longnecker DS; Roebuck BD; Bell RH Ann N Y Acad Sci; 1994 Mar; 713():439-41. PubMed ID: 8018216 [No Abstract] [Full Text] [Related]
9. Effects of cholecystokinin and bombesin on development of azaserine-induced pancreatic tumours in rats: modulation by the cholecystokinin receptor antagonist lorglumide. Meijers M; Appel MJ; van Garderen-Hoetmer A; Lamers CB; Rovati LC; Jansen JB; Woutersen RA Carcinogenesis; 1992 Sep; 13(9):1525-8. PubMed ID: 1394835 [TBL] [Abstract][Full Text] [Related]
10. Effect of lorglumide (CR-1409) on pancreatic secretory and trophic response to caerulein in newborn rats. Papp M; Varga G; Folly G Acta Physiol Hung; 1991; 78(1):61-7. PubMed ID: 1722380 [TBL] [Abstract][Full Text] [Related]
11. Inhibitory effects of estrogen and castration on the early stage of pancreatic carcinogenesis in Fischer rats treated with azaserine. Sumi C; Longnecker DS; Roebuck BD; Brinck-Johnsen T Cancer Res; 1989 May; 49(9):2332-6. PubMed ID: 2706621 [TBL] [Abstract][Full Text] [Related]
12. CR-1409: a potent inhibitor of cholecystokinin-stimulated amylase release and cholecystokinin binding in rat pancreatic acini. Iwamoto Y; Yamamoto R; Kuzuya T Pancreas; 1987; 2(1):85-90. PubMed ID: 2437574 [TBL] [Abstract][Full Text] [Related]
13. Overexpression of cholecystokinin receptors in azaserine-induced neoplasms of the rat pancreas. Bell RH; Kuhlmann ET; Jensen RT; Longnecker DS Cancer Res; 1992 Jun; 52(12):3295-9. PubMed ID: 1596887 [TBL] [Abstract][Full Text] [Related]
14. Effects of long-term CCK stimulation and CCK blockade on pancreatic and intestinal growth, morphology, and function. Niederau C; Lüthen R; Niederau M; Strohmeyer G; Ferrell LD; Grendell JH Digestion; 1990; 46 Suppl 2():217-25. PubMed ID: 2262055 [TBL] [Abstract][Full Text] [Related]
15. Inhibition by retinoids of the growth of azaserine-induced foci in the rat pancreas. Roebuck BD; Baumgartner KJ; Thron CD; Longnecker DS J Natl Cancer Inst; 1984 Jul; 73(1):233-6. PubMed ID: 6610790 [TBL] [Abstract][Full Text] [Related]
16. Effects of dietary fats and soybean protein on azaserine-induced pancreatic carcinogenesis and plasma cholecystokinin in the rat. Roebuck BD; Kaplita PV; Edwards BR; Praissman M Cancer Res; 1987 Mar; 47(5):1333-8. PubMed ID: 3815341 [TBL] [Abstract][Full Text] [Related]
17. Different actions of CCK on pancreatic and gastric growth in the rat: effect of CCK(A) receptor blockade. Varga G; Kisfalvi K; Pelosini I; D'Amato M; Scarpignato C Br J Pharmacol; 1998 Jun; 124(3):435-40. PubMed ID: 9647465 [TBL] [Abstract][Full Text] [Related]
18. Differential effects of atropine and a cholecystokinin receptor antagonist on pancreatic secretion. Adler G; Reinshagen M; Koop I; Göke B; Schafmayer A; Rovati LC; Arnold R Gastroenterology; 1989 Apr; 96(4):1158-64. PubMed ID: 2647576 [TBL] [Abstract][Full Text] [Related]
19. Modulation of putative preneoplastic foci in exocrine pancreas of rats and hamsters. I. Interaction of dietary fat and ethanol. Woutersen RA; van Garderen-Hoetmer A; Bax J; Feringa AW; Scherer E Carcinogenesis; 1986 Sep; 7(9):1587-93. PubMed ID: 2943527 [TBL] [Abstract][Full Text] [Related]
20. Effects of L-364,718, a new cholecystokinin receptor antagonist, on camostate-induced growth of the rat pancreas. Wisner JR; McLaughlin RE; Rich KA; Ozawa S; Renner IG Gastroenterology; 1988 Jan; 94(1):109-13. PubMed ID: 3335282 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]